Inhibrx Biosciences family trust buys 5,000 shares
Separate entries show additional shares in two revocable trusts and custodial accounts for Child A and Child B.
Rhea-AI Filing Summary
The Jon F. Kayyem and Paige Gates-Kayyem Family Trust purchased 5,000 common shares of Inhibrx Biosciences, Inc. (INBX) at $100 per share on September 23, 2026, bringing its reported holdings to 434,360 shares. Director Jon Faiz Kayyem disclaims beneficial ownership of the trust shares except to the extent of any indirect pecuniary interest in his distributive shares.
Other listed indirect positions included 250,000 shares in each of the Jon Faiz Kayyem Revocable Trust and Paige Gates-Kayyem Revocable Trust, and 69,843 shares in each custodial account for Child A and Child B. Kayyem disclaims beneficial ownership of the children's account shares except to the extent of any indirect pecuniary interest in his distributive shares.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock F1 | 5,000 | $100.00 | $500K |
| holding | Common Stock F2 | -- | -- | -- |
| holding | Common Stock F3 | -- | -- | -- |
| holding | Common Stock F4 | -- | -- | -- |
| holding | Common Stock F5 | -- | -- | -- |
Footnotes (5)
- F1. These securities are directly owned by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust. Jon Faiz Kayyem is the trustee of The Jon Faiz Kayyem and Paige N. Gates Family Trust and he disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein.
- F2. These securities are directly owned by the Jon Faiz Kayyem Revocable Trust, of which Jon Faiz Kayyem is the trustee.
- F3. These securities are directly owned by the Paige-Gates Kayyem Revocable Trust, of which Jon Faiz Kayyem's spouse is the trustee.
- F4. These securities are directly owned by a custodial account managed by the reporting person for the benefit of the reporting person's minor child, Child A. The reporting person disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein.
- F5. These securities are directly owned by a custodial account managed by the reporting person for the benefit of the reporting person's minor child, Child B. The reporting person disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein.
Key Figures
Key Terms
indirect pecuniary interest financial
beneficial ownership regulatory
custodial account financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Was the INBX purchase reported under a Rule 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.